Channel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CHRO and buy or sell other stocks, ETFs, and their options commission-free!About CHRO
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil.
CEOScott M. Plesha
CEOScott M. Plesha
Employees4
Employees4
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded
Founded
Employees4
Employees4
CHRO Key Statistics
Market cap41.72M
Market cap41.72M
Price-Earnings ratio-1.21
Price-Earnings ratio-1.21
Dividend yield—
Dividend yield—
Average volume23.50K
Average volume23.50K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$54.29
52 Week high$54.29
52 Week low$5.62
52 Week low$5.62
Stock Snapshot
The current Channel Therapeutics(CHRO) stock price is $13.50, with a market capitalization of 41.72M. The stock trades at a price-to-earnings (P/E) ratio of -1.21.
During the trading day, Channel Therapeutics(CHRO) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Channel Therapeutics(CHRO) stock has reached 0, versus its average volume of 23.5K.
Over the past 52 weeks, Channel Therapeutics(CHRO) stock has traded between a high of $54.29 and a low of $5.62.
Over the past 52 weeks, Channel Therapeutics(CHRO) stock has traded between a high of $54.29 and a low of $5.62.
People also own
Based on the portfolios of people who own CHRO. This list is generated using Robinhood data, and it’s not a recommendation.